A prognostic nomogram based on lymph node skipping metastases in esophageal squamous cell carcinoma.

IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM
Journal of thoracic disease Pub Date : 2025-04-30 Epub Date: 2025-04-27 DOI:10.21037/jtd-24-1798
Wen-Hui Hou, Li Jie, Liao Yao, Yu-Wei Yang, He Fang, Yuan-Yuan Zhao, Xian-Yan Chen, You-Ling Gong, Xiao-Bo Du
{"title":"A prognostic nomogram based on lymph node skipping metastases in esophageal squamous cell carcinoma.","authors":"Wen-Hui Hou, Li Jie, Liao Yao, Yu-Wei Yang, He Fang, Yuan-Yuan Zhao, Xian-Yan Chen, You-Ling Gong, Xiao-Bo Du","doi":"10.21037/jtd-24-1798","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>At present, the definition of lymph node skipping metastases (NSM) in esophageal squamous cell carcinoma (ESCC) is not uniform, and there were few clinical prognostic models with NSM as a factor. On the other hand, N-staging of ESCC has long been controversial. This study aimed to define NSM in ESCC and investigate its prognostic implications. Meanwhile, according to the cumulative number of cervical, thoracic and abdominal region lymph nodes, a new N-stage was defined and compared with the N-stage of American Joint Committee on Cancer/the Union for International Cancer Control (AJCC/UICC) and Japan Esophageal Society (JES).</p><p><strong>Methods: </strong>ESCC patients who underwent radical esophagectomy with lymph node metastases (LNM) between January 2012 and December 2022 at Mianyang Central Hospital and West China Hospital of Sichuan University. Patients were grouped into training and external validation cohorts. NSM was defined as any LNM outside the primary tumor region. Meanwhile, this study created a new postoperative pathology N-staging [PN(n)] based on the regional division of LNM to compare with the 8th edition of the AJCC/UICC and the 11th edition of JES N-staging.</p><p><strong>Results: </strong>There were 232 patients enrolled (training: 161; validation: 71). Cox-regression identified factors that could predict outcomes independently. Kaplan-Meier survival analysis was performed. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and calibration plots. Independent risk factors for death included NSM [hazard ratio (HR) =1.5202], age (HR =1.036), T-stage (HR =2.874), and AJCC/UICC N stage (HR =1.9601). Prognostic models for 1-year (AUC: 0.923, 0.985), 3-year (AUC: 0.747, 0.746), and 5-year (AUC: 0.695, 0.713) survival showed high accuracy.</p><p><strong>Conclusions: </strong>NSM is associated with worse overall survival (OS) in ESCC, and the constructed prognostic model effectively predicts OS for ESCC patients.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"17 4","pages":"1942-1957"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093065/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-24-1798","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: At present, the definition of lymph node skipping metastases (NSM) in esophageal squamous cell carcinoma (ESCC) is not uniform, and there were few clinical prognostic models with NSM as a factor. On the other hand, N-staging of ESCC has long been controversial. This study aimed to define NSM in ESCC and investigate its prognostic implications. Meanwhile, according to the cumulative number of cervical, thoracic and abdominal region lymph nodes, a new N-stage was defined and compared with the N-stage of American Joint Committee on Cancer/the Union for International Cancer Control (AJCC/UICC) and Japan Esophageal Society (JES).

Methods: ESCC patients who underwent radical esophagectomy with lymph node metastases (LNM) between January 2012 and December 2022 at Mianyang Central Hospital and West China Hospital of Sichuan University. Patients were grouped into training and external validation cohorts. NSM was defined as any LNM outside the primary tumor region. Meanwhile, this study created a new postoperative pathology N-staging [PN(n)] based on the regional division of LNM to compare with the 8th edition of the AJCC/UICC and the 11th edition of JES N-staging.

Results: There were 232 patients enrolled (training: 161; validation: 71). Cox-regression identified factors that could predict outcomes independently. Kaplan-Meier survival analysis was performed. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and calibration plots. Independent risk factors for death included NSM [hazard ratio (HR) =1.5202], age (HR =1.036), T-stage (HR =2.874), and AJCC/UICC N stage (HR =1.9601). Prognostic models for 1-year (AUC: 0.923, 0.985), 3-year (AUC: 0.747, 0.746), and 5-year (AUC: 0.695, 0.713) survival showed high accuracy.

Conclusions: NSM is associated with worse overall survival (OS) in ESCC, and the constructed prognostic model effectively predicts OS for ESCC patients.

基于食管鳞状细胞癌淋巴结转移的预后形态图。
背景:目前,食管鳞状细胞癌(ESCC)中淋巴结跳跃性转移(NSM)的定义尚不统一,将NSM作为预后因素的临床模型较少。另一方面,ESCC的n分期一直存在争议。本研究旨在定义ESCC中的NSM并探讨其预后意义。同时,根据颈部、胸部和腹部淋巴结的累积数目,定义新的n期,并与美国癌症联合委员会/国际癌症控制联盟(AJCC/UICC)和日本食管学会(JES)的n期进行比较。方法:2012年1月至2022年12月在四川大学绵阳中心医院和华西医院行根治性食管切除术并淋巴结转移(LNM)的ESCC患者。患者被分为训练组和外部验证组。NSM被定义为原发肿瘤区域外的任何LNM。同时,本研究基于LNM的区域划分,创建了新的术后病理n分期[PN(n)],与第8版AJCC/UICC和第11版JES n分期进行比较。结果:共纳入232例患者(培训:161例;验证:71)。cox回归确定了可以独立预测结果的因素。进行Kaplan-Meier生存分析。利用接收机工作特性曲线(AUC)下面积和标定图对模型性能进行评价。死亡的独立危险因素包括NSM[危险比(HR) =1.5202]、年龄(HR =1.036)、t分期(HR =2.874)、AJCC/UICC N分期(HR =1.9601)。1年(AUC: 0.923, 0.985)、3年(AUC: 0.747, 0.746)和5年(AUC: 0.695, 0.713)生存率预测模型准确率较高。结论:NSM与ESCC患者较差的总生存期(OS)相关,构建的预后模型可有效预测ESCC患者的OS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信